# Use First, Trust Later? Exploring How Health Care Providers View the Gaps Between AI’s Regulation and Its Implementation

**Authors:** Aviad Raz, Yael Inbar, Ziv Paz, Barkan Hofman, Zalman Itzhakov, Orly Weinstein

PMC · DOI: 10.2196/74038 · JMIR Formative Research · 2025-11-10

## TL;DR

This paper explores how healthcare providers view the gap between AI regulation and its real-world use in healthcare.

## Contribution

It highlights the need for ongoing oversight and quality assurance during early AI adoption in healthcare.

## Key findings

- Regulatory focus on premarket approval limits AI's adaptiveness in healthcare.
- Healthcare providers need to manage AI quality assurance during early adoption.
- Ongoing oversight is crucial for AI implementation in real-world settings.

## Abstract

The regulatory focus on premarket approval, overlooking and limiting the life cycle, real-world adaptiveness potential of artificial intelligence in health care, requires ongoing oversight and quality assurance by health care providers–cum-deployers, especially during early adoption.

## Full-text entities

- **Diseases:** hemorrhages (MESH:D006470), AI (MESH:C538142), trauma (MESH:D014947), heart failure (MESH:D006333)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12599978/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12599978/full.md

---
Source: https://tomesphere.com/paper/PMC12599978